Prevalence rates for early childhood asthma in the United States show marked racial/ethnic and socio-economic disparities that taper with age.

In COPD, respiratory morbidity and mortality are associated with airway luminal narrowing, a change that can be measured.

Timely remdesivir treatment in immunocompromised patients infected with COVID-19 is associated with improved survival outcomes.

Cancer patients may require COVID-19 vaccinations more often than the general public, but guidance is needed, researchers say.

Children with health care-associated vs nonhealth care-associated RSV were more likely to require escalation of respiratory support.

Using GLI Global vs GLI Caucasian spirometry equations in pediatric patients aged 18 and younger was linked to significant changes in z-scores.

Patients with CRSwNP have a high burden of SCS use and associated health care costs, especially when they have comorbid asthma.

Remdesivir treatment reduces the risk for 30-day COVID-19-related hospital readmission among all patients discharged alive from initial hospitalization.

Baricitinib is an effective treatment option for children and adolescents with atopic dermatitis, with no new safety signals identified.

Upadacitinib was superior to dupilumab for the treatment of atopic dermatitis in the head and neck, trunk, upper limbs, and lower limbs.

Among health care personnel, influenza vaccination has not returned to 2019 levels, and COVID-19 vaccinations have been decreasing.

Dupilumab was effective for patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP) at 52 weeks.